No credit card. No commitment.
5000+ G2 reviews
Global Blood Therapeutics
Research
Public company
Founded in 2011
South San Francisco, CaliforniaGlobal Blood Therapeutics
ResearchPublic companyFounded in 2011South San Francisco, California
EmployeesGlobal Blood Therapeutics' financial review
Global Blood Therapeutics' Revenue (Yearly)
71.6M
Employees
120
Total Funding
353.7M
Last Funding Round
150M
nasdaq
GBT
Market cap
4.6B
Global Blood Therapeutics information
Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission on behalf of people living with sickle cell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content.
Global Blood Therapeutics industries
Biotechnology
Life sciences
Research
Biotechnology: pharmaceutical preparations
Global Blood Therapeutics' financial review
Global Blood Therapeutics' Revenue (Yearly)
71.6M
Employees
120
Total Funding
353.7M
Last Funding Round
150M
nasdaq
GBT
Market cap
4.6B
Employee Metrics
Technologies
Customer Relationship Management
Email Providers
Other
Hosting
Other
Other
Global Blood Therapeutics' Competitors
Notable Alumni
Employees
Blood Bank Technologist
GBT Medical Affairs, Medical Director For Brazil and LATAM
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
